We are live on ! Find out more
TRLV

Trulieve Cannabis Corp

14 hedge funds and large institutions have $3.1M invested in Trulieve Cannabis Corp in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1414 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

49% less capital invested

Capital invested by funds: $6.08M → $3.1M (-$2.98M)

Holders
14
Holders Change
Holders Change %
0%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change

TRLV Hedge Fund Activity: Q2 2022 in Review

14 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Trulieve Cannabis Corp (TRLV) for Q2 2022, worth a combined $3.1M — down 49% from $6.08M a quarter earlier.

Fund positioning in TRLV was balanced in Q2 2022: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 3 trimmed.

The largest buyer was Empire Life Investments, opening a new position worth an estimated $395K. The largest seller was Tamarack Advisers, cutting an estimated $487K.

  • 14 institutional investors held Trulieve Cannabis Corp (TRLV) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $3.1M of Trulieve Cannabis Corp stock for Q2 2022, down 49% quarter-over-quarter.
  • 3 funds opened new Trulieve Cannabis Corp positions in Q2 2022 and 3 closed out, a net change of 0 holders.
  • The largest Trulieve Cannabis Corp buyer in Q2 2022 was Empire Life Investments, an estimated $395K added.
  • The largest Trulieve Cannabis Corp seller in Q2 2022 was Tamarack Advisers, an estimated $487K sold.

Based on aggregated 13F filings for Q2 2022.